Riverside Insights, a portfolio company of Alpine Investors, announced that it has acquired ImPACT Applications.
Both Riverside and ImPACT Applications are committed to delivering robust research-based assessment tools to educators and healthcare providers. ImPACT Applications, Inc. is the maker of ImPACT®, ImPACT Pediatric®, and ImPACT Quick Test®, all FDA cleared Class I & II medical devices that assist in the screening, assessment, and management of concussion. ImPACT Applications products are used by thousands of major medical centers, professional sports leagues and teams, colleges, high schools, and select military units around the globe. Since 2002, ImPACT Applications has administered more than 18 million tests to over 11 million users.
“We are excited to partner with Riverside,” said CEO Mike Wahlster. “ImPACT Applications and Riverside both share the same vision for empowering customers with tools that are developed from world-class research and driving better outcomes for students and patients.”
To read more, visit the press release here.
